February #56 : House of Trials - by Joseph Wilbeck

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

HIV: Behind The Music

A Star Is Torn

Free Your Mind

Everyday Grace


Marriage Vows

House of Trials

In The Works


Shout Out

Getting Testy

Love Me

Shout Out

The Times, They Are a Changin’

Say What?

Catching Up With?

Never A Dull Momentum

All Aboard The Love Boat


Special Ed

Of Dykes & Data

Dead on Approval

Take the Cake

Dances With Woolf

Sweet Chariot

Heart Beat

Hitting Below The Belt

She’s A Big Girl Now

To Good To Be The Flu

Herb Of The Month

Prevention Suspension

Comfort Zone

Easy as C&E

Shelf Life

2.07.84: Eureka!

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

February 2000

House of Trials

by Joseph Wilbeck

Drug companies looking for subjects to enroll in clinical trials just love prisons—they hold plenty of people who are not only hungry for potential treatments but good bets to keep appointments. And though the nation’s correctional system has a documented history of abuse of trial participants, some prisoners and their advocates now want in.

Last fall, Brown University’s HIV Education/ Prison Project (HEPP) Clinical Trials in Corrections conference brought together health, prison and legal experts to hash out the issue. “This is only the beginning of a long process,” said HEPP’s Betsy Stubblefeld, one of the confab organizers. “This is the first time since the ’70s that the prospect is even
being discussed.”

With few rights and little recourse against mistreatment, prisoners are in a tricky situation. Their regular health care may be so poor—particularly in prison systems without a history of good patient care—that a trial is their only hope for adequate treatment, let alone new, costly drugs. But incentive may not be balanced by information, according to Judy Greenspan, chair of California Prison Focus’ HIV in Prison committee. Under ideal circumstances, participation in drug trials demands considerable treatment knowledge. But prison libraries don’t have comprehensive materials, and, according to Greenspan, for prisoners with rare access to any other information about new meds, it’s hard to make an informed decision.

“Prisoners are the guinea pigs of choice,” said Allen Hornblum, who wrote Acres of Skin, an exposé about medical abuse in Philadelphia’s Holmesburg Prison. “With so many liberties taken by doctors and pharmaceutical companies, you have to be extremely suspicious of their motivations.”

The issue isn’t going anywhere fast—conference participants have been slow to produce guidelines for safe trials. Because some states prohibit trials outright, said Greenspan, often the most effective method is for a prison doctor to work with community organizations, pushing for an OK to approve trials in a particular prison “on an emergency basis.” Four states—Florida, Texas, North Carolina and Maryland—are already allowing prisoners to enroll in trials. Whether or not all the hassle will drive drug companies away for good remains to be seen.  

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.